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Abstract
Background: Numerous studies examined factors in promoting a patient preference for active participation in
treatment decision making with only modest success. The purpose of this study was to identify types of patients
wishing to participate in treatment decisions as well as those wishing to play a completely active or passive role
based on a Germany-wide survey of dialysis patients; using a prediction typal analysis method that defines types as
configurations of categories belonging to different attributes and takes particularly higher order interactions
between variables into account.
Methods: After randomly splitting the original patient sample into two halves, an exploratory prediction configural
frequency analysis (CFA) was performed on one-half of the sample (n = 1969) and the identified types were
considered as hypotheses for an inferential prediction CFA for the second half (n = 1914). 144 possible prediction
types were tested by using five predictor variables and control preferences as criterion. An a-adjustment (0.05) for
multiple testing was performed by the Holm procedure.
Results: 21 possible prediction types were identified as hypotheses in the exploratory prediction CFA; four patient
types were confirmed in the confirmatory prediction CFA: patients preferring a passive role show low information
seeking preference, above average trust in their physician, perceive their physician’s participatory decision-making
(PDM)-style positive, have a lower educational level, and are 56-75 years old (Type 1; p < 0.001) or > 76 years old
(Type 2; p < 0.001). Patients preferring an active role show high information seeking preference, a higher
educational level, and are < 55 years old. They have either below average trust, perceive the PDM-style negative
(Type 3; p < 0.001) or above average trust and perceive the PDM-style positive (Type 4; p < 0.001).
Conclusions: The method prediction configural frequency analysis was newly introduced to the research field of
patient participation and could demonstrate how a particular control preference role is determined by an
association of five variables.
Background
Patients’ preferences for involvement in treatment
decisions
According to Charles and colleagues [1], there are three
different models for describing patient-physician interac-
tion. In the “paternalistic model”, the physician makes
treatment decisions to the best of his knowledge for the
good of the patient without including the patient in the
decision-making process. In the meantime, the patient
passively acquiesces to the professional authority of the
physician by agreeing to the physician’s choice of treat-
ment. In the “informed model”, the physician is respon-
sible for providing patients with relevant information on
all treatment options as well as their benefits and risks,
while the patients are then responsible for making the
treatment decision. Unlike in the two previous models,
in the “shared model”, both the physician and the
patient have an equal share in the decision-making
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mation between physician and patient and both agree
on the final treatment decision [2].
The need to establish a physician-patient partnership
when making treatment decisions is less compelling in
t h ec a s eo fe v e r y d a yp r o b l e m sw i t hc l e a rd i a g n o s i sa n d
treatment paths than in the case of chronic, serious or
life-threatening illnesses, for which there are several
treatment options with different risks and benefits [1].
Shared decision making (SDM) has already shown to
lead to improved treatment outcomes for chronically ill
patients [3]. One-time treatment decisions made for the
treatment of short, acute illnesses are often completely
different from recurrent treatment decisions made for
the therapy of chronic illnesses [4]. Alongside the well-
known factors of physician-patient communication and
of patient contributions and efforts, recent studies on
the involvement of patients in making medical decisions
have identified a third key factor: the contributions and
efforts of the physicians involved [4,5]. The addition of
the physicians’ emphasis to the process of establishing a
partnership is seen as a critical point in adapting SDM
to chronic care decision making. During treatment of
chronically ill patients, physicians and patients can
engage in an ongoing information exchange followed by
deliberation followed by more information exchange
followed by further deliberation and so forth, while trust
and partnership evolve alongside [4]. Other researchers
suggest that physicians vary widely in how much they
facilitate patients’ active participation in treatment deci-
sions, what they have termed a “participatory decision-
making style” [6].
Shared decision making has gained importance as an
approach to physician-patient communication and
patient participation in recent years. For this reason,
several self-report and objective scales for assessing
aspects of patient participation already exist [7]. From a
patient’s perspective, the control preference construct
measures “the degree of control an individual wants to
assume when decisions are made about medical treat-
ment” [8]. In the process patients are presented five
descriptions of different roles in treatment decision
making, which they have to consider in expressing their
preferences.
Numerous studies have already examined the question
as to whether and to what extent patients wish to take
part in making decisions about their own health [9-15].
However, there are only few studies that report the deci-
sion making role preferences of dialysis patients. In this
case, 42% of both Canadian and English participants in
a study showed a definite desire to participate in treat-
ment decision making, while 35% of Canadian patients
and only 19% of English patients preferred to play an
active role [16,17]. Two large US studies using a slightly
different measurement method revealed that more than
half of the participating patients (54%, 76% respectively)
wanted to have at least a part of the responsibility in
decision making [18,19]. Initial studies of the state and
developmental tendencies of SDM among patients with
end-stage renal disease (ESRD) in Germany showed that
dialysis patients were greatly willing to play an active
role in the decision-making process [20].
Numerous studies, which have examined the desired
involvement of patients in making treatment decisions,
have used univariate or multivariate analyses in an
attempt to identify determinants of the preference for
active participation in treatment decision making. The
results of these studies are not quite clear, yet they indi-
cate several tendencies. For instance, various studies
were able to confirm that the older the patients were,
the less likely they were to prefer an active role
[9,10,21-24]. In contrast, yet other studies demonstrated
that the age of patients had no influence on the patients’
preferred role [12,25]. Studies also showed that a higher
level of education attained by patients is positively asso-
ciated with preferences for active participation
[9,12,15,22,24-26] or has no influence [10] on the
patients’ desire to participate. In cases of newly estab-
lished physician-patient relationships, the involvement
of patients in making treatment decisions significantly
increased the patients’ level of trust in their physicians
[27], while patients that had already developed a high
level of trust expressed less of a desire to play an active
role in decision making [28,29]. When asked how their
medical treatment could be improved, patients
responded that their top priority is to get more informa-
tion from their treating physician [30]. This does not
mean, however, that patients with a heightened need for
information also necessarily wish to take on responsibil-
ity for their treatment decisions [22,30,31].
Configural frequency analysis
Configural frequency analysis (CFA) is a procedure for
analyzing multivariate cross-classifications that can be
used in a wide range of multivariate experimental
designs. Among the advantages of CFA often mentioned
are: it is suitable for data on a nominal scale level and it
is distribution-free. It allows further a profile-oriented
analysis, which means the unit of an analysis is the pro-
file or configuration of all observed values of a person
[32]. In contrast to latent class analysis, CFA operates at
the level of manifest variables and latent classes are
neither assumed nor created. Further, CFA aims at iden-
tification of outstanding cells of multivariate cross-
classifications instead of fitting a model. It seeks to iden-
tify patterns that stand outa sm o r ef r e q u e n t( C F A
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chance [33]. Another advantage is that unlike many
other methods, CFA does not use a similarity or dis-
tance measure to identify types, but takes only types
into consideration with identical attribute patterns,
which makes its type definition more accurate than any
other previous type definition [34]. Further, other meth-
ods, like factor-analytical methods, yield a clustering of
variables and not of persons. Another problem with
typal analyses based on correlation matrices (like factor
analysis) is that they take into consideration only first-
order interactions of the variables. All types that are
caused by higher-order interactions alone cannot be
detected by these methods [34]. Configural frequency
analysis has already been widely used in psychological,
social, and medical research: CFA has proven to be use-
ful in determining Wechsler Profile Types [35] and clas-
sifying headache syndromes [36,37]. Other researchers
succeeded in predicting constellations of social support
at work in the development of low back pain by CFA
[38] or finding factors associated with the transition
from abuse to dependence among substance abusers
[39]. Further, CFA was used for examining adult psy-
chopathy and violent behaviour in males with early
neglect and abuse [40] or exploring bacterial sets in per-
iodontal health and disease [41]. Other studies used
CFA for examining histologic criteria and tumour beha-
viour of patients with gastrointestinal stromal tumours
[42] or gene expression levels in testicular germ cell
tumours [43].
In order to give physicians the opportunity to involve
patients according to their wishes in the medical treat-
ment process, attempts have repeatedly been made to
predict patients’ behaviour regarding participatory pre-
ferences by using sociodemographic and/or psychosocial
factors [10,23,26,44]. However, only a single study by
Adams and colleagues [26] has thus far been able to
explain 48% of the variance in their model using a mul-
tiple linear regression analysis involving a group of Aus-
t r a l i a na s t h m ap a t i e n t s .T h ep r e s e n ts t u d ys e e k st o
predict the preferred decision-making roles of German
patients with end-stage renal disease (ESRD) through
the comprehensive application of sociodemographic and
psychosocial factors. The employed factors consisted of
age, educational level, information-seeking preference,
trust in physician, and physicians’ participatory deci-
sion-making (PDM) style. Using the specific method of
prediction CFA, this study goes a step further with
regards to a precise and robust means of identifying the
types of patients wishing to participate in treatment
d e c i s i o n sa sw e l la st h o s ew i s h i n gt op l a yac o m p l e t e l y
active or passive role as found in previous literature on
this topic.
Methods
Sampling and data collection
The present study was conducted with patients of the
non-profit Kuratorium fuer Dialyse und Nierentrans-
plantation e. V. (KfH). 15000 of the 60992dialysis
patients in Germany [45] are currently treated in the
physician-run facilities of this institution. The KfH has
implemented a quality assurance program QiN (Quality
in Nephrology). All dialysis units of the KfH have the
opportunity to take part in QiN voluntarily; in 2005
QiN was attended by 187 dialysis centres. QiN provides
a large database of the included dialysis patients on var-
ious clinical data. In addition, QiN conducts a survey
concerning health-related quality of life, once a year.
Therefore, the 187 participating dialysis units obtained
questionnaires from QiN for delivery to every patient
who was treated in the unit during the fourth quarter of
the year (October 1 to December 31, 2005). The staff of
each unit was responsible for informing the patients
about the purpose of the survey and the delivery of the
q u e s t i o n n a i r ei n c l u d i n gar e t u r ne n v e l o p et ot h ei n d i v i -
dual patient. The dialysis units were also responsible for
sending the completed questionnaires back to QiN. The
dialysis units received 14972 questionnaires for distribu-
tion among their patients. Since none of the individual
dialysis centers kept count of how many survey ques-
tionnaires had actually been distributed to their patients,
a concrete response rate could not be calculated. How-
ever, 6318 questionnaires were returned to QiN, which
could be used for statistical analysis.
In the fourth quarter of 2005, questions concerning
participation in treatment decision-making were
included in the QiN health-related quality of life survey.
Whereas previous studies of people with renal disease
focused on the decision between haemodialysis and peri-
toneal dialysis in the SDM process [17,46], this decision
(haemodialysis) had already been made for the patients
of this study. Nevertheless, there are various decisions
that also need to be made during outpatient haemodia-
lysis. For example, the patient can participate in the
decision about how long, how often, at what time, and
in which institution the dialysis should be administered,
and how their comorbidities (e.g., hypertonia, diabetes)
should be treated.
Study design
For analyzing the present data, a modification of the
configural frequency analysis was used, the so-called
prediction configural frequency analysis. In conducting
the prediction analysis, the overall sample of patients
with no missing values was later randomly divided into
two equal-sized subsamples [47]. In the first subsample,
types were identified using the prediction CFA. In this
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control preferences of the patients when making treat-
ment decisions (active role, collaborative role, passive
role) by using five predictor variables (information-seek-
ing preference, trust in physician, physicians’ participa-
tory decision-making (PDM) style, educational level, and
age). It is foreseeable that with many attributes the
number of configurations and types, respectively,
becomes so large that only sparse types can be detected.
In this case one performs with one sample an explora-
tory CFA without a-adjustment. Then, within a second
independent sample, inferential analyses are calculated
only for those configurations which provided explora-
tory types in the first analysis. Therefore, in the second
subsample, a prediction CFA was performed as cross-
validation by way of the inferential verification (with a-
adjustment [48]) of the types identified in the explora-
tory analysis (Figure 1).
Configural frequency analysis
For a CFA, several attributes of a sample of subjects were
observed. Each observed attribute consist though of dif-
ferent categories. Further, for each subject the value of
each category is observed, which constitute the so called
configurations. The number of individuals that a specific
configuration exhibits is counted and these numbers are
then recorded in a contingency table as absolute frequen-
cies [34]. The values for each configuration
X observed frequency expected frequency expected frequ
2 2 = () − /e ency
can be assessed under the null hypothesis of the total
independence using critical values for the chi-square
distribution for 1 degree of freedom [49].
In prediction CFA, one is interested in predicting certain
configurations by means of other configurations. For this
purpose, the attributes or variables are divided into two
subsets: predictor variables and criterion variables. This
means in the present study that information-seeking pre-
ference, trust in physician, physicians’ participatory deci-
sion-making (PDM) style, educational level, and age are
considered as predictor variables, while the control prefer-
ences scale is regarded as the criterion to be predicted.
The absolute frequencies of all possible configurations are
entered in a contingency table as in CFA. However, for
each cell with a given frequency a fourfold table is derived.
A prediction type is assumed if the probability of the joint
incidence of the configurations is greater than under the
null hypothesis on the independence of the variables. This
is calculated by using Fisher exact tests [49]. A technical
description and a calculation example for a (prediction)
CFA is given in Additional file 1.
Measures
The control preferences scale (criterion variable)
The control preferences scale [10,50] identifies the type of
participation patients wish to have in making treatment
decisions. Patients have the opportunity to choose
between five different statements about their desired type
of participation. The options range from autonomous
decision making by the patient (= active role; two response
options), to participatory decision making between physi-
cian and patient (= collaborative role; one response
option), to the physician having sole responsibility for
decision making (= passive role; two response options). A
“pick one approach” - a paper version of the scale that was
originally developed as a card sorting approach - was used
[8]. In the process, patients were asked to consider all five
interaction styles and select the one that felt closest to
their preferred role in treatment decision making.
Predictor variables
The first predictor variable identified the patients’ desire
for information (Information subscale of the Autonomy
Preference Index [22]). The scale consists of 8 items,
which were answered on a Likert scale of 1 (strongly
agree) to 5 (strongly disagree). Sum scores were calcu-
lated and two categories of the attribute (high and low)
were established via median dichotomization.
The second predictor variable demonstrates the trust
that the patients have in their physician [51]. The scale
Figure 1 Study design.
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scale with responses ranging from 1 (completely dis-
agree) to 4 (completely agree). Since the median of the
sum scores of this scale is also the maximum value, the
mean was chosen for categorization, which was some-
what lower than the median. Thus, two prediction
values are obtained: less than the mean value and
greater than the mean value.
The third predictor variable corresponds to the
patient’s perceived involvement by the physician, mea-
sured by the Physicians’ Participatory Decision-Making
Style scale [52]. The scale consists of 3 items for which
there are two different 5-point Likert response scales (e.
g. “How often does your doctor ask you to take some of
the responsibility for your treatment? (very often to not
at all); If there were a choice between treatments, would
your doctor ask you to help make the decision? (defi-
nitely yes to definitely no)”) .S i n c et h es c a l ec o n s i s t s
only of 3 items with very different response scales it was
decided to categorize it by the individual item content
rather than by calculating a sum score. However,
because the Likert scale items are scaled in the same
direction (positive - negative), it was resolved that at
least two of the three scale items had to be answered in
the same direction in order to identify two categories of
the physician’s PDM style (positive and negative).
The educational level and age of the patients consti-
tute the fourth and fifth predictor variables. In the pro-
cess, the educational level was subdivided into two
categories (low: no secondary school certificate or lower
secondary school certificate; high: secondary school cer-
tificate and higher, and age was subdivided into three
categories (≤ 55 years; 56 - 75 years; ≥ 76 years). The
categories for educational level and age were determined
so that they fit the distribution of the data.
Analyses
When analyzing the prediction configural frequency
analysis, all configurations of the five predictors were
generated. The five predictors were: M1 = Information-
seeking preference (with 1 = low, 2 = high), M2 = Trust
in physician (with 1 = < average, 2 = > average), M3 =
Physicians’ PDM style (with 1 = negative, 2 = positive),
M4 = Educational level (with 1 = low, 2 = high) and M5
=A g e( w i t h1=≤ 55 years, 2 = 56 - 75 years, 3 = ≥ 76
years). The predictors were supposed to predict the
one-dimensional criterion M6 = Control preferences
(with 1 = active role, 2 = collaborative role and 3 = pas-
sive role). As statistical verification of the configural
t y p e s2×2×2×2×3×3=1 4 4F i s h e re x a c tt e s t s
were calculated. The prediction CFA was performed
using the software developed by Krauth [53].
An a-adjustment (0.05) for multiple testing was per-
formed by means of the Holm procedure, a more
powerful approach than the Bonferroni procedure.
Holm proposed a simple sequentially rejective procedure
by ordering the p-values and comparing them with Bon-
ferroni adjustments [48].
Results
Sample characteristics
In total, data were collected from n = 6318 haemodialy-
sis’ patients of the KfH via questionnaires. A comparison
of the KfH patient population (about 15000 patients) to
the “average German patient” with renal replacement
therapy [45], which was only possible when comparing
age and gender because of a lack of comparative data,
showed that the KfH patients were representative of all
dialysis patients in Germany regarding gender and age.
In order to ensure that the overall study sample of 6318
patients was representative of the KfH patient popula-
tion, both groups were compared with regard to their
gender, age, educational level, length of their dialysis
treatment, and their Karnofsky Index. The results
showed the study sample to be representative of the
overall population of KfH patients (data not shown).
Nonetheless, the patients of the exploratory and the
confirmatory samples (n = 1969; n = 1914), with no
missing values, are distinguishable from participants in
the overall study sample (n = 6318) by a slightly lower
average age (2 and 1 years less, respectively), a slightly
higher educational level (3% more patients with a high
educational level within the exploratory sample), a
higher need for information (7% more patients with a
high need for information within the exploratory and
the confirmatory samples), and 3% more males within
both subsamples. However, because of their minimal
occurrence, these characteristics are not regarded as
restrictive to the validity of the samples. No differences
were found regarding the control preferences. As the
patients were randomly assigned to either exploratory or
confirmatory sample and as the two subsamples were
large, it was expected that only differences due to ran-
dom error would be found. The results were in line
with this expectation (Table 1).
Prediction analysis
21 possible prediction types were identified (printed in
bold) in the exploratory sample shown in Table 2. Con-
sequently, the Fisher exact test of these configurations
demonstrated a p- v a l u e<0 . 0 5 .O ft h e2 1p o s s i b l ep r e -
diction types that were identified, 8 configurations pre-
dicted the preference to play an active role in treatment
decisions, 4 configurations predicted the desire to play a
collaborative role, and 9 configurations predicted the
desire to play a passive role. The 21 predictor configura-
tions were then considered as hypotheses for the confir-
matory prediction CFA.
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ment was performed, but only on the potential 21 types
identified in the exploratory analysis (Figure 2). In the
process, verification was provided for prediction type
(12212)×3 labelled as “T1 ”, type (12213)×3 labelled as
“T2 ”, type (21121)×1 labelled as “T3 ” and type
(22221)×1 labelled as “T4 ”.
It is predicted that dialysis patients preferring a pas-
sive role in treatment decisions (Type 1) demonstrate a
low desire for information, have an above-average level
of trust in their treating physician and have a positive
perception of their physician’s PDM style. In addition,
these patients have a low educational level and are
either between the ages of 56 and 75 or they are age 76
and older (Type 2).
Furthermore, it is predicted that patients with a high
desire for information prefer to play an active role. In
addition, these patients have a high educational level
and are at most 55 years old. Furthermore, the trust
that these patients have in their physicians can be char-
acterized as below-average and they have a negative per-
ception of their physicians’ PDM style (Type 3). Type 4
patients show an above-average level of trust in their
physician, and a positive perception of their physician’s
PDM style (Table 3).
Discussion
When predicting the control preference, the greatest
contrast was found between the active and passive types’
desire for information, their educational level and their
age. In addition, the passive types always demonstrated
above-average trust in their physician and a positive per-
ception of their involvement by their physician in deci-
sion making (their physician’s PDM style), whereas the
active types could also exhibit a below-average level of
trust in their physician together with a negative percep-
tion of their physician’s PDM style (Table 3).
These results are supported in parts by the reports of
other researchers: multivariate studies have already
shown that the desire for active participation in treat-
ment decision-making increases in patients with a
higher educational level [26,44] and a somewhat lower
age [44] and tends to decrease the older the patients
and the lower their educational level [54]. These reports
also found a correlation between a positive perception
of the physician’s involvement of the patient due to his
PDM style and the desire for increased participation
[26]. Kraetschmer and her colleagues [29] reported that
patients preferring a passive role had a high level of
trust in their treating physician and study participants
preferring an active role had little trust in their physi-
cian. Hall et al. [55] found evidence for a generally high
level of trust in the patients’ physicians (90% or more of
the patients). The trust values demonstrated by patients
in this study could be explained in connection with the
perceived values of the physician’s PDM style: if there is
a positive perception of the PDM style, then the
patient’s trust in the physician increases (Type 1, Type
2, Type 4). The opposite is also true: if there is a nega-
tive perception of the physician’s PDM style, then the
patient’s trust in the physician decreases (Type 3). This
study was not designed in such a way that causal direc-
tion between trust and perception of the physician’s
PDM style can be assumed. However, findings from lit-
erature suggest that trust of patients increases as a result
of patients being satisfied with the physician’sP D M
style: although the development of a trusting relation-
ship is not completely clarified, trust is believed to
evolve over time and is shaped by patients’ experiences
and interactions with their physicians. This was shown
on a sample of patients establishing a new physician-
patient relationship: patients, who were involved in
Table 1 Patient characteristics
Exploratory
sample
(n = 1969)
Confirmatory
sample
(n = 1914)
Gender
Male 60.9% (1199) 60.8% (1164)
Female 39.1% (770) 39.2% (750)
Age (years)
Mean (Range) 63.9 (18-94) 64.6 (20-96)
≤ 55 years 26.4% (519) 24.1% (462)
56 - 75 years 48.1% (947) 48.9% (935)
≥ 76 years 25.5% (503) 27.0% (517)
Years on dialysis
Mean (Range) 4.6 (0-33) 4.8 (0-38)
Karnofsky performance index*
Mean (Range) 74 (10-100) 74 (10-100)
Decision-making preference
Active role 22.4% (442) 22.2% (424)
Collaborative role 31.3% (616) 30.8% (589)
Passive role 46.3% (911) 47.1% (901)
Educational level
Low 65.9% (1297) 68.6% (1313)
High 34.1% (672) 31.4% (601)
Information-seeking preference
Low 38.9% (765) 38.9% (744)
High 61.1% (1204) 61.1% (1170)
Trust in physician
Below average 34.1% (672) 35.4% (677)
Above average 65.9% (1297) 64.6% (1237)
Physicians’ PDM style
Negative 38.1% (750) 39.0% (747)
Positive 61.9% (1219) 61.0% (1167)
* Karnofsky performance index: assessment tool used to assist clinicians/
caretakers in measuring a patient’s ability to carry out activities of daily living
(e.g.: Normal, no complaints, no evidence of disease = 100; requires
considerable assistance and frequent medical care = 50; Dead = 0).
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confirmatorysamples
Predictor configurations Exploratory sample*
(n = 1969)
Confirmatorysample
†
(n = 1914)
M6 M6
M1 M2 M3 M4 M5 1 2 3 123
11111 0.868561 0.013433 0.965462 0.132716 0.250897 0.988444
11112 0.986465 0.566994 0.065148 0.651998 0.589635 0.438021
11113 0.837806 0.943782 0.044112 0.869598 0.816498 0.109900
11121 0.003995 0.558877 0.998703 0.040347 0.743055 0.946179
11122 0.206284 0.377986 0.945128 0.063365 0.643754 0.942566
11123 0.167299 0.870319 0.760671 0.950949 0.766104 0.141515
11211 0.387803 0.863616 0.492469 0.161224 0.974986 0.549439
11212 0.736882 0.012917 0.979951 0.975624 0.845271 0.018431
11213 0.999647 0.802734 0.004485 0.996089 0.357889 0.178549
11221 0.000526 0.719929 1.000000 0.060949 0.046314 0.999981
11222 0.428826 0.380616 0.855444 0.557708 0.357889 0.786593
11223 1.000000 0.312849 1.000000 0.481830 0.924178 0.436117
12111 0.857129 0.683738 0.290362 0.851363 0.441130 0.517129
12112 0.999620 0.531546 0.014243 0.972254 0.923865 0.007423
12113 0.967847 0.997609 0.000459 0.946666 0.936227 0.014773
12121 0.404697 0.895093 0.584079 0.024306 0.890320 0.978174
12122 0.835002 0.575279 0.370051 0.387784 0.052811 0.998311
12123 0.869697 0.769805 0.284715 0.777927 0.269913 0.861121
12211 0.490653 0.406689 0.752028 0.717236 0.823456 0.238753
12212 0.980595 0.860401 0.007893 0.999999 0.718093 0.000058 T1
12213 0.999730 0.946691 0.000071 0.999980 0.915213 0.000060 T2
12221 0.122222 0.613263 0.908054 0.018876 0.421608 0.997229
12222 0.506892 0.784709 0.393508 0.772922 0.589417 0.366223
12223 0.978426 0.434567 0.216913 0.915578 0.889245 0.042856
21111 0.010568 0.240021 0.999566 0.010179 0.650267 0.978838
21112 0.120891 0.218840 0.981613 0.303068 0.058791 0.988485
21113 0.771296 0.051227 0.952478 0.620639 0.103562 0.923111
21121 0.000000 0.912684 0.999979 0.000000 T3 0.836925 0.999998
21122 0.000008 0.897191 0.999555 0.010179 0.949048 0.869418
21123 0.463636 0.093064 0.988886 0.319816 0.287885 0.970943
21211 0.013963 0.206085 0.999954 0.029721 0.349747 0.995546
21212 0.456875 0.044917 0.981564 0.079130 0.395506 0.968858
21213 0.273647 0.928973 0.509020 0.996089 0.104609 0.473831
21221 0.000145 0.411609 0.999990 0.007815 0.772473 0.980082
21222 0.155768 0.233927 0.983029 0.099956 0.405697 0.971317
21223 1.000000 0.068152 0.801432 0.077756 0.467936 0.993923
22111 0.600728 0.713610 0.400621 0.034337 0.257264 0.997223
22112 0.974082 0.757745 0.031957 0.996559 0.302793 0.092598
22113 0.975795 0.121327 0.519333 0.855271 0.936875 0.036585
22121 0.059371 0.977447 0.530169 0.114972 0.136279 0.997053
22122 0.213526 0.769220 0.693151 0.087146 0.837020 0.789409
22123 0.794185 0.029025 0.961348 0.961883 0.180994 0.682467
22211 0.075093 0.803607 0.782896 0.106104 0.469835 0.936655
22212 0.999969 0.467800 0.001904 0.999989 0.244953 0.006359
22213 0.999868 0.745509 0.001138 0.991909 0.868168 0.004507
22221 0.001424 0.431570 0.999327 0.000080 T4 0.312023 0.999994
22222 0.750593 0.667267 0.246865 0.135057 0.574359 0.589893
22223 0.490653 0.798727 0.380271 0.842434 0.711906 0.194625
Predictor variables: M1 = Information-seeking preference (1 = low, 2 = high), M2 = Trust in physician (1 = < average, 2 = > average), M3 =P h y s i c i a n s ’ PDM style (1 =
negative, 2 = positive), M4 = Educational level (1 = low, 2 = high), and M5 = Age (1 = ≤ 55 years, 2 = 56-75 years, 3 = ≥ 76 years), and criterion variable: M6 =C o n t r o l
preferences (1 = active role, 2 = collaborative role, 3 = passive role). *possible prediction types are printed in bold. †confirmed prediction types are marked with a “T”.
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Page 7 of 11decisions as much as they wanted, expressed greater
trust in their physicians after their first physician-patient
contact [27].
Since “need for information” was the only attribute
that was marginally higher in the exploratory and con-
firmatory subsamples (by 7%) than in the overall study
sample of 6318 patients, particular attention was paid to
predictor-criterion configurations with low p-values with
regard to informational desire. If the predictor-criterion
configurations (11121)×1 with P11121 × 1 = 0.040347
and (12221)×1 with P12221 × 1 = 0.018876 (Table 2,
confirmatory sample) are therefore taken into account
when interpreting the prediction types, the result is that
t h ea c t i v er o l ei sp r e f e r r e dr e g a r d l e s so ft h ei n f o r m a -
tional desire of patients age 55 and younger with a high
educational level. These patients have either a below-
average level of trust in their physician together with a
negative perception of the physician’s PDM style or they
have an above-average trust in their physician along
with a positive perception of the physician’s PDM style.
Additionally, if the predictor-criterion configurations
(22212)×3 with P22212 × 3 = 0.006359 and (22213)×3
with P22213 × 3 = 0.004507 (Table 2, confirmatory
sample) are considered, the passive role is preferred
regardless of the informational desire of patients with an
above-average level of trust in their physician, a positive
perception of their physician’s PDM style, a low educa-
tional level and age older than 56 years (56 to 75 years
old or older than 75). It was found that the informa-
tional desire of patients was independent of their pre-
ferred active or passive control preference. Although
these results cannot be confirmed by cross-validation,
they are supported by the literature on this topic: there
have been several reports that although patients desired
information about their upcoming treatment, they did
n o tw a n tt ob ei n v o l v e di nt h et r e a t m e n td e c i s i o n s
[31,56]. Ende and his colleagues [22] also confirmed this
in that they could find no correlation between the desire
for information and the preferred decision-making roles
of patients. The present study also showed that although
the patients demonstrated a high desire for information,
47% of those surveyed wished to play a passive role in
making treatment decisions.
Some of the associations that were revealed by the
prediction configural frequency analysis could be sup-
ported by findings from the literature, as just presented.
However, when two variables are associated only under
the condition that one or more other variables take a
specific value, Pearsons correlations would only be mod-
erate and associations could not be revealed by the use
of e.g. factor analysis. Though, their common occur-
rence would still be detected by means of CFA that is
also sensitive when higher-order interactions between
variables are present [37]. The prediction configural fre-
quency analysis used to predict the control preferences
of patients in making treatment decisions, took into
account interactions between variables of the fifth order.
Even though logistic regression and prediction CFA
focus on the same data characteristics, on the relations
among predictor variables and criterion, standard mod-
els of logistic regression (a variable-oriented approach)
and prediction CFA (a person-oriented approach) vary.
For this reason, results from both methods can not be
compared or interpreted without further analyses and
extension of the logistic regression model [57]. Never-
theless, it would be interesting to compare results
between prediction CFA and other typal analyses or
(logistic) regression models with regard to patients’
preferences.
Limitations
When interpreting the findings of this study, considera-
tion needs to be given to a number of methodological
issues. The participating patients were recruited at 187
dialysis centres. Thus the design of this study was in
fact a multilevel approach, which was not considered in
the analyses. Therefore, the results might be biased, if
Figure 2 a-Adjustment procedure.
Table 3 Confirmed Patient Types
Passive Role Passive Role Active Role Active Role
Type 1 (n = 91) Type 2 (n = 45) Type 3 (n = 29) Type 4 (n = 26)
Information-seeking preference low low high high
Trust in physician > average > average < average > average
Physicians’ PDM style positive positive negative positive
Educational level low low high high
Age 56 -75 years ≥ 76 years ≤ 55 years ≤ 55 years
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Page 8 of 11interactions between physicians’ behaviour and dialysis
centres may occur. However, since the number of parti-
cipating dialysis units was very high (187), this was not
considered as threatening to the validity of the study
results.
In order to ensure that the overall study sample was
representative of the KfH patient population, it was
shown that both groups were comparable with regard to
their gender, age, educational level, length of their dialy-
sis treatment, and their Karnofsky Index. However, it
might be that the relevant motives to participate in this
study or not are psychological of nature, which may
introduce selection bias.
The prediction CFA was performed as cross-validation
by splitting the original sample into two subsamples.
However, it might be interesting to confirm the study
results in further independent populations.
Due to the selected study group of chronically ill
patients with end-stage renal disease, the results of this
study may only be carefully transferred to other physi-
cian-patient interactions or as well as other patient
groups. As a follow-up study, it would still be interesting
to verify whether the prediction types found in this
study using the above-mentioned procedure can be con-
firmed in other populations such as e.g. breast cancer
patients.
The generalisability of results may further be limited
by errors associated with survey non-response and item
non response.
In addition, the current condition of the chronically ill
patients could differ widelyf r o mo n ea n o t h e r :s o m eo f
the patients might have decided on the treatment of
their comorbidities and some patients on changing their
health behaviour. Although the seriousness of such a
decision and its implications could affect the decision-
making preferences, it is not clear to what extent this
would influence the results of the present study. Future
studies on medical decision-making would benefit from
including some measures of the patients medical condi-
tion. Additionally, some patients may have had difficul-
ties in understanding the role descriptions of the control
preferences scale [58], whose effects on the results can-
not be assessed.
Furthermore, the questionnaire was given at a single
time in the course of treatment while trust is a factor
that is assumed to vary with time and according to the
clinical experiences and outcomes. However, the assess-
ment of trust in our study is based on long-term experi-
ences of patients. All patients that took part in the
survey have been under long-term treatment in the par-
ticipating facilities. Most of them were able to establish
a stable relationship with their physician over time
which is based more or less on trust depending on the
character of the relationship.
Ethical approval for this survey was obtained by the
Ethical Committee Board of the University Hospital of
Cologne.
Conclusions
The prediction CFA approach is new to the field of
patient participation and could show in contrast to the
above mentioned research studies, how a particular con-
trol preference role is determined by an association of
five variables. Further research should aim at increasing
the percentage of participants representing a type by
carefully choosing different combinations of psychologi-
cal, social and medical parameters. The more accurate
patient types become, the better will be the ability of the
treating physicians to meet the specific needs of each
patient concerning participation in treatment decisions.
This is of particular importance when establishing a
long-term relationship with chronically ill patients.
Additional material
Additional file 1: Calculation of a prediction CFA. The method
prediction configural frequency analysis is described in detail and
demonstrated by calculating an example.
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